Detection of magnetic nanoparticles in tissue using magneto-motive ultrasound

Nanotechnology

Volumn 17, Issue 16, 2006, Pages 4183-4190

  Oh, Junghwan ^a   Feldman, Marc D ^b   Kim, Jeehyun ^c   Condit, Chris ^a   Emelianov, Stanislav ^a   Milner, Thomas E ^a  

^a The University of Texas at Austin   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; DRUG DOSAGE; IRON OXIDES; NANOTECHNOLOGY; SUPERPARAMAGNETISM; TISSUE;

INTRAVENOUS ADMINISTRATION; MURINE LIVER MACROPHAGES; SUPERPARAMAGNETIC IRON OXIDE (SPIO) NANOPARTICLES; ULTRASONIC DETECTION;

ULTRASONIC IMAGING;

EID: 33748904804     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/17/16/031     Document Type: Article

References (34)

1. Correas J M, Bridal L, Lesavre A, Mejean A, Claudon M and Helenon O 2001 Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts Eur. Radiol. 11 1316-28
2. Kedar R P, Cosgrove D, McCready V R, Bamber J C and Carter ER 1996 Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress Radiology 198 679-86
3. Wilson S R, Burns P N, Muradali D, Wilson J A and Lai XM 2000 Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis Radiology 215 153-61
4. Shi W T, Forsberg F, Hall A L, Chia R Y, Liu J B, Miller S, Thomenius K E, Wheatley M A and Goldberg B B 1999 Subharmonic imaging with microbubble contrast agents: initial results Ultrason. Imaging 21 79-94
5. Marsh J N, Hall C S, Scott M J, Fuhrhop R W, Gaffney P J, Wickline S A and Lanza G M 2002 Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model IEEE Trans. Ultrason. Ferroelectr. Freq. Control 49 29-38
6. Renkin E M 1977 Multiple pathways of capillary permeability Circ. Res. 41 735-43
7. Jaffer F A and Weissleder R 2005 Molecular imaging in the clinical arena JAMA 293 855-62
8. Marchal G, Van Hecke P, Demaerel P, Decrop E, Kennis C, Baert A L and van der Schueren E 1989 Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T AJR Am. J. Roentgenol. 152 771-5
9. Hundt W, Petsch R, Helmberger T and Reiser M 2000 Effect of superparamagnetic iron oxide on bone marrow Eur. Radiol. 10 1495-500
10. Reimer P, Jahnke N, Fiebich M, Schima W, Deckers F, Marx C, Holzknecht N and Saini S 2000 Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis Radiology 217 152-8
11. Harisinghani M G, Barentsz J, Hahn P F, Deserno W M, Tabatabaei S, van de Kaa C H, de la Rosette J and Weissleder R 2003 Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N. Engl. J. Med. 348 2491-9
12. Anzai Y, Blackwell K E, Hirschowitz S L, Rogers J W, Sato Y, Yuh W T, Runge V M, Morris M R, McLachlan S J and Lufkin R B 1994 Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer Radiology 192 709-15
13. Boraschi P, Donati F, Volpi A and Campori G 2005 On the AJR viewbox. Intrapancreatic accessory spleen: diagnosis with RES-specific contrast-enhanced MRI AJR Am. J. Roentgenol. 184 1712-3
14. Weissleder R, Stark D D, Engelstad B L, Bacon B R, Compton C C, White D L, Jacobs P and Lewis J 1989 Superparamagnetic iron-oxide-pharmacokinetics and toxicity Am. J. Roentgenol. 152 167-73
15. Wang Y X, Hussain S M and Krestin G P 2001 Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging Eur. Radiol. 11 2319-31
16. Nolte I, Vince G H, Maurer M, Herbold C, Goldbrunner R, Solymosi L, Stoll G and Bendszus M 2005 Iron particles enhance visualization of experimental gliomas with high-resolution sonography Am. J. Neuroradiol. 26 1469-74
17. Schmitz S A, Coupland S E, Gust R, Winterhalter S, Wagner S, Kresse M, Semmler W and Wolf K J 2000 Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits Invest. Radiol. 35 460-71
18. Schmitz S A, Taupitz M, Wagner S, Wolf K J, Beyersdorff D and Hamm B 2001 Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles J. Magn. Reson. Imaging 14 355-61
19. Petri-Fink A, Chastellain M, Juillerat-Jeanneret L, Ferrari A and Hofmann H 2005 Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells Biomaterials 26 2685-94
20. Ross R 1999 Atherosclerosis is an inflammatory disease Am. Heart J. 138 S419-20
21. Litovsky S, Madjid M, Zarrabi A, Casscells S W, Willerson JT and Naghavi M 2003 Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo-Enhancement by tissue necrosis factor-alpha, interleukin-1 beta, and interferon-gamma Circulation 107 1545-9
22. Turetschek K, Roberts T P, Floyd E, Preda A, Novikov V, Shames D M, Carter W O and Brasch R C 2001 Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model J. Magn. Reson. Imaging 13 882-8
23. Remsen L G, McCormick C I, Roman-Goldstein S, Nilaver G, Weissleder R, Bogdanov A, Hellstrom I, Kroll R A and Neuwelt E A 1996 MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis AJNR Am. J. Neuroradiol. 17 411-8
24. Kooi M E, Cappendijk V C, Cleutjens K B J M, Kessels A G H, Kitslaar P J E H M, Borgers M, Frederik P M, Daemen MJAP and van Engelshoven J M A 2003 Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging Circulation 107 2453-8
25. Taschner C A, Wetzel S G, Tolnay M, Froehlich J, Merlo A and Radue E W 2005 Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors AJR Am. J. Roentgenol. 185 1477-86
26. Turetschek K, Roberts T P L, Floyd E, Preda A, Novikov V, Shames D M, Carter W O and Brasch R C 2001 Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model J. Magn. Reson. Imaging 13 882-8
27. Aristizabal O, Christopher D A, Foster F S and Turnbull DH 1998 40-MHz echocardiography scanner for cardiovascular assessment of mouse embryos Ultrasound Med. Biol. 24 1407-17
28. Kundu T, Bereiter-Hahn J and Karl I 2000 Cell property determination from the acoustic microscope generated voltage versus frequency curves Biophys. J. 78 2270-9
29. Lubbe A S, Alexiou C and Bergemann C 2001 Clinical applications of magnetic drug targeting J. Surg. Res. 95 200-6
30. Weissleder R and Mahmood U 2001 Molecular imaging Radiology 219 316-33
31. Perez J M, Simeone F J, Tsourkas A, Josephson L and Weissleder R 2004 Peroxidase substrate nanosensors for MR imaging Nano Lett. 4 119-22
32. Josephson L, Tung C H, Moore A and Weissleder R 1999 High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates Bioconjug. Chem. 10 186-91
33. Hergt R, Hiergeist R, Zeisberger M, Glockl G, Weitschies W, Ramirez P, Hilger I and Kaiser W A 2004 Enhancement of AC-losses of magnetic nanoparticles for heating applications J. Magn. Magn. Mater. 280 358-68
34. Kalambur V S, Han B, Hammer B E, Shield T W and Bischof JC 2005 In vitro characterization of movement, heating and visualization of magnetic nanoparticles for biomedical applications Nanotechnology 16 1221-33